APA (7th ed.) Citation

CS, C., LCD, N., SH, Y., R, R., N, A., NS, Z., . . . GG, G. (2026). Immune response to SARS-CoV-2 vaccination among chronic myeloid leukaemia patients on tyrosine kinase inhibitors. Annals of the Academy of Medicine, Singapore, 55(4), 179. https://doi.org/10.47102/annals-acadmedsg.2025368

Chicago Style (17th ed.) Citation

CS, Cheong, et al. "Immune Response to SARS-CoV-2 Vaccination Among Chronic Myeloid Leukaemia Patients on Tyrosine Kinase Inhibitors." Annals of the Academy of Medicine, Singapore 55, no. 4 (2026): 179. https://doi.org/10.47102/annals-acadmedsg.2025368.

MLA (9th ed.) Citation

CS, Cheong, et al. "Immune Response to SARS-CoV-2 Vaccination Among Chronic Myeloid Leukaemia Patients on Tyrosine Kinase Inhibitors." Annals of the Academy of Medicine, Singapore, vol. 55, no. 4, 2026, p. 179, https://doi.org/10.47102/annals-acadmedsg.2025368.